ArticleFrontiers in oncology2026
Case Report: Dermoscopic and pathologic features of primary cutaneous follicle center lymphoma involving the nasal ala.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary cutaneous follicle center lymphoma (PCFCL) is a rare, indolent B-cell lymphoma that typically presents as asymptomatic lesions on the scalp, forehead, or trunk, with disease confined to the skin. Involvement of the nasal region is highly uncommon and prone to misdiagnosis because of its nonspecific clinical features. Case description: An 84-year-old woman presented with a collection of asymptomatic, firm, agminated papules on the left nasal ala, first noted about 2 years prior. At dermoscopy, the lesions presented fine, linear, irregular vessels on a salmon-colored background. The histopathological evaluation revealed nodular lymphoid infiltrates within the dermis, a prominent grenz zone, and well-demarcated lymphoid follicles composed of atypical lymphocytes with a thin mantle zone. The immunohistochemical analysis showed diffuse positivity for CD20, BCL6 and CD10, and negativity for BCL2 and CD5 in the atypical cells, which were surrounded by a thin layer of CD3-positive reactive T lymphocytes. The diagnosis of PCFCL was established on the basis of the clinical, dermoscopic, and histopathologic findings, and curative radiation therapy was initiated. Conclusion: PCFCL involving the nasal ala is extremely rare and presents with nonspecific dermoscopic patterns that may delay or obscure diagnosis. Accurate identification relies on the integration of dermoscopic assessment, histopathological examination, and immunohistochemical profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.